Morgan Stanley Sees Attractive Entry Point for Abbott Laboratories
April 17, 2014 at 09:44 AM EDT
In a report published Thursday, Morgan Stanley analyst David R. Lewis reiterated an Overweight rating and $45.00 price target on Abbott ...